Title : Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment.

Pub. Date : 2021 Jun 30

PMID : 34209110






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These results suggest that the proposed compounds, in addition to Camostat and Nafamostat, could be effective TMPRSS2 inhibitors for COVID-19 treatment by occupying the S1 pocket with the hallmark positively charged groups. nafamostat transmembrane serine protease 2 Homo sapiens